Sunovion Sees Advantage For Aptiom As Unscheduled Epilepsy Drug

Dainippon subsidiary plans to launch its next-generation version of carbamazepine in the second half of 2014. Lack of classification as a controlled substance means more direct access to prescribers, company says.